Question 1

What are the potential side effects of MDV3100 and docetaxel?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Tolerability Study of MDV3100 in Combination With Docetaxel in Men With Advanced Prostate Cancer clinical trial (NCT01565928). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to other options I have?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Tolerability Study of MDV3100 in Combination With Docetaxel in Men With Advanced Prostate Cancer clinical trial (NCT01565928). Contact the study team or your healthcare provider for specific answers.

Question 3

What will my treatment schedule look like if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Tolerability Study of MDV3100 in Combination With Docetaxel in Men With Advanced Prostate Cancer clinical trial (NCT01565928). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any specific tests or monitoring required during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Tolerability Study of MDV3100 in Combination With Docetaxel in Men With Advanced Prostate Cancer clinical trial (NCT01565928). Contact the study team or your healthcare provider for specific answers.

Question 5

How will this trial impact my current treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Tolerability Study of MDV3100 in Combination With Docetaxel in Men With Advanced Prostate Cancer clinical trial (NCT01565928). Contact the study team or your healthcare provider for specific answers.

Question 6

What support will be available for me during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Tolerability Study of MDV3100 in Combination With Docetaxel in Men With Advanced Prostate Cancer clinical trial (NCT01565928). Contact the study team or your healthcare provider for specific answers.

What this study is about